Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?

Urology

Volumn 54, Issue 5, 1999, Pages 846-852

  Djavan, Bob ^a   Zlotta, Alexandre R ^b   Remzi, Mesut ^a   Ghawidel, Keywan ^a   Bursa, Bernd ^a   Hruby, Stephan ^a   Wolfram, Roswitha ^a   Schulman, Claude C ^b   Marberger, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0032729041     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00329-5     Document Type: Article

References (11)

1. Catalona W.J., Smith D.S., Wolfert R.L., et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 274:1995;1214-1220.
2. Partin A.W., Carter H.B. The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer. Urol Clin North Am. 23:1996;531-540.
3. Vashi A.R., Wojno K.J., Henricks W., et al. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system. Urology. 49:1997;19-27.
4. Djavan B., Zlotta A.R., Byttebier G., et al. Prostate specific antigen density of the transition zone for early detection of prostate cancer. J Urol. 160:1998;411-419.
5. Benson M.C., Whang I.S., Pantuck A., et al. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol. 147:1992;817-821.
6. Lepor H., Wang B., Shapiro E. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology. 44:1994;199-205.
7. Stephan C., Lein M., Jung K., et al. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer. 79:1997;104-109.
8. Catalona W.J., Richie J.P., deKernion J.B., et al. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer receiver operating characteristic curves . J Urol. 152:1994;2031-2036.
9. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 270:1993;860-864.
10. Lein M., Koenig F., Jung K., et al. The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer establishment of reference ranges in a large population of healthy men . Br J Urol. 82:1998;231-236.
11. España F., Martínez M., Royo M., et al. Reference ranges for the concentrations of total and complexed plasma prostate-specific antigen and their ratio in patients with benign prostate hyperplasia. Eur Urol. 32:1997;268-272.